Introduction
Teratogenic effects of antiepileptic drugs (AEDs) are well known. [1] [2] [3] [4] Approximately 0.3% of all pregnant women have epilepsy and is in need of a balanced AED treatment. 5 To optimize AED treatment regimens, good characterization of risks is required not only for malformations but also for effects on fetal growth. To date, most attention regarding intrauterine effect of anticonvulsants has been given to the malformations. However, Hvas et al. showed that newborns of women with drug treated epilepsy had lower birth weight, length, and head circumference (HC) but normal gestational age compared to newborns of women without epilepsy, and that none of these negative effects was present in cases of untreated maternal epilepsy. 6 Also, a few other studies reported a decrease in body dimensions, especially a reduced HC, after AED exposure in utero, where polytherapy often showed stronger growth reduction effect than monotherapy did. [7] [8] [9] Of the ''old generation'' AEDs, phenobarbital, phenytoin, primidone, ethosuximide, carbamazepine (CBZ), clonazepam and valproic acid/valproat (VPA), some have been studied regarding effect on fetal growth in small samples. To the ''new generation'' of AEDs belong drugs introduced in the 1990 s and later, including vigabatrin, lamotrigine, gabapentin, felbamate, oxcarbazepine, topiramate, levetiracetam, pregabalin, zonizamide and clobazam. CBZ and VPA are still the most commonly used AEDs in most developed countries. An AED-induced effect on fetal head growth has been found primarily for CBZ. Hiilesmaa et al. studied 133 Finnish children exposed to AEDs in utero and showed that CBZ alone, and in polytherapy with phenobarbital, was associated with fetal head growth retardation. 8 In a European material of 577 infants exposed to AEDs it was found that VPA treatment was associated with a doubling of the risk for major malformations, whereas CBZ had negative effects on body weight, length and HC at birth. 7 On the contrary, Battino et al. found a lower risk for small HC after exposure to CBZ compared to VPA and pentobarbital monotherapies among 315 newborns. 10 Interestingly, there was a significant trend for lower effect over time of CBZ on HC in a Swedish population-based study with births from 1973 to 1997. 9 Their data were based on a material of 963 women on AED treatment where HC and gestational age were reduced by CBZ, but neither intrauterine growth, birth weight or body length was. Other Seizure 18 (2009) monotherapies were studied together as a group and no negative consequences on body dimensions were found. With this investigation we have estimated the effect on head growth of exposure in utero to the new AEDs lamotrigine and gabapentin and the old AEDs phenytoin, clonazepam, CBZ and VPA. The large size of our material made it possible to study risks that were previously estimated based on few exposures. Further, we studied changes in the use and effects of AED over time.
Materials and methods
2.1. AED effect on birth-weight-adjusted head circumference (bwadj-HC) in newborns after exposure in utero
We analyzed data from the Swedish Medical Birth Registry (SMBR) in which all newborns in Sweden are registered (National Board of Health). Information on maternal drug use was collected from a structured interview made by a midwife at the first antenatal visit (usually around 10-12 gestational weeks). Thereafter, prescriptions from the antenatal care system given after the first visit were recorded. In this study, a record any time during pregnancy counted as use of antiepileptic drug. All infants born 1995-2005 where the mother reported use of AEDs were selected (n = 2718). From this group the following numbers of newborns were excluded: six with reported CNS malformation and 64 who were twins or triplets, and 223 infants without known birth weight or HC. The remaining group consisted of 2426 newborns, that is, 0.27% of all singleton infants with known birth weight and HC, without known CNS malformations and with a record from the first antenatal care visit (n = 900,739 comprising the population group of comparison).
The population infants were grouped by birth weight in 500 g intervals. For each birth weight group the mean and SD of HC were calculated for all newborns for each stratum according to year of birth, maternal age (2 classes: <35 years, !35 years), parity (2 classes: 1, >1), maternal smoking (3 classes: 0 or no answer, <10, !10 cigarettes per day), maternal body mass index (3 classes: <19.8, 19.8 BMI < 26, !26 kg/m 2 ).
Quantitative analysis
For each infant exposed to AED in utero, its HC deviation from the mean HC of the infant's birth weight group in the population data, according to year of birth, maternal age, parity, smoking, and BMI, was calculated and expressed as the number of standard deviations (SDs) in that stratum, a standard deviation score (SDS). The mean of these SDS among the exposed infants was compared with zero in t tests using two-sided tests and the standard error of the mean (SEM) for the SDS. The effect of exposure to AED on bwadj-HC was determined for infants exposed to any AED and also for infants exposed to some specific drugs individually, used in monotherapy or polytherapy. Differences in effects between the three periods 1995-1997, 1998-2001 and 2002-2005 were studied using analysis of variance.
Dichotomous analysis
We also estimated the impact of AED exposure on the occurrence of microcephaly (bw-adj-HC smaller than 2 SD below the expected mean) with a Mantel-Haenszel analysis, adjusting for the same confounders as above and using Miettineń s method to estimate approximative 95% CI.
Association between mothers' AED treatment during pregnancy and their own bw-adj-HC at birth
Among the mothers to the 2426 newborns exposed in utero to AED in 1995-2005, 1017 were born after 1973 and none after 1988. Of those, 862 had their own birth recorded in SMBR and for 850 of those there were data on birth weight and birth HC. The control population consisted of all now living women born 1973-1988 according to SMBR with data on birth weight and HC. The control population of women was grouped by birth weight in 500 g intervals. For each birth weight group the mean and SD of the womens' birth HC were calculated for each stratum according to year of birth. For each woman treated with AED, her birth HC deviation from the mean birth weight specific HC, expected from the population data according to year of birth was determined and expressed as standard deviation score (SDS). The mean of these SDS for those treated with AED was compared with zero in t tests using two-sided tests and the SEM for the SDS.
The Swedish ethical board at Karolinska Institutet approved the study. Table 1 presents population data on mean HC with SD according to birth weight class.
Results
The frequencies of the various antiepileptic drugs among singleton pregnancies for the whole period are listed in Table 2 . Monotherapies represented 90% of the cases (n = 2195). CBZ was clearly the most commonly used drug (50% of the monotherapies), followed by VPA (21%), and lamotrigine (14%). Among the 231 polytherapies, the majority (216) consisted of two AEDs.
3.1. Birth-weight-adjusted head circumference at birth (bw-adj-HC)
Quantitative analysis
A significantly smaller mean bw-adj-HC was found among newborns to mothers treated with AED compared to all births during 1995-2005 (0.10 SDS units from mean of the population, t = 4.8, p < 0.001). The effects on bw-adj-HC of the specific AEDs used in more than 50 cases were determined (Table 3) . CBZ had the strongest negative effect on bw-adj-HC. The effect was found to be of the same order of magnitude for monotherapies (SDS = 0.15, t = 4.8, p < 0.001) and polytherapies (SDS = 0.17, t = 1.9, p = 0.07). VPA in monotherapy also had a negative effect on mean bw-adj-HC (SDS = 0.10, t = 2.1, p = 0.04). The other drugs analyzed; phenytoin, clonazepam, lamotrigine and gabapentin in monotherapy showed no effect on mean bw-adj-HC.
Analyses were performed in three groups of year of birth separately: [1995] [1996] [1997] [1998] [1999] [2000] [2001] 
Dichotomous analysis
Microcephaly (a bw-adj-HC smaller than 2 SD below the expected mean) occurred in 2.6% of all infants and in 3.3% of the infants exposed to AED in utero. The adjusted odds ratio (OR) for having an infant with microcephaly after exposure to any AED in polytherapy was 2.85 (95% CI: 1.74-4.78). However, in monotherapy the risk for microcephaly was increased neither after any AED (OR = 1.17, 95% CI: 0.91-1.51), after CBZ alone (OR = 1.26, 95% CI: 0.89-1.77) nor after VPA alone (OR = 1.14, 95% CI: 0.65-1.98). 
Discussion
In this study we analyzed the effect on head circumference of exposure in utero to AEDs during 1995-2005 in a large nation-wide Swedish material. The analyses were adjusted for year of birth, maternal age, parity, smoking, and body mass index. The most commonly used monotherapies were CBZ, followed by VPA, lamotrigine, and phenytoin. A significant reduction of mean birth-weight-adjusted head circumference (bw-adj-HC) was seen after CBZ and VPA monotherapy. The effects of CBZ and VPA corresponded to 0.2-0.4 cm. An increased risk of microcephaly (HC smaller than 2 SD below expected mean) was statistically significant after polytherapy but not after monotherapy or monotherapy with CBZ or VPA. The possibility that the association between AED exposure and bw-adj-HC of the newborn was due to inheritance of small bw-adj-HC from the mother was tested. The mean bw-adj-HC of the mothers to the infants exposed to AED was compared to that of all women born in the same year interval, 1973-1988, adjusting for year of birth. The mothers treated with AED corresponded to almost half of the cohort of the AED-exposed infants studied. The mothers treated with AED had similar bw-adj-HC as the general female population suggesting that mothers' bwadj-HC at birth was not a confounding factor.
CBZ was also previously shown to reduce body dimensions of the newborn, primarily HC. 8 However, a decline in the effect was previously suggested in an earlier Swedish study. 9 No decline in effect of CBZ on bw-adj-HC over time was observed in the present study spanning 7 additional years with more than double the population size. VPA was in a previous small study shown to reduce HC stronger than CBZ, 10 however other small studies (n = 62 and 30) showed no VPA effect on HC. 7, 11 None of the other four AEDs studied, phenytoin, clonazepam, lamotrigine and gabapentin, showed a significant effect on mean bw-adj-HC. Previous findings on effects of in utero exposure to the AEDs studied here include the following. The effects on mean HC of CBZ and VPA are similar, if anything higher for CBZ than VPA, [7] [8] [9] [10] whereas VPA but not CBZ has probable clinically relevant malforming effect. 12 Both CBZ and phenytoin monotherapies possibly increase the risk for cleft palate, 12 but phenytoin has not been associated with microcephaly. 13 Benzodiazepines usually have a low malforming potential and small studies of clonazepam in monotherapy (n = 43) had little information value. 14, 15 Few studies on the fetal effect of gabapentin have been published. In a study of the safety of gabapentin exposure in human pregnancy no increased risk was found compared to the general population but also this study had a low power due to the small number of patients (n = 39). 16 A recent study showed various malformations of the brain in mice fetuses after gabapentin exposure in utero. 17 A dose-dependent malforming effect of lamotrigine has been published, 18 but this finding was not reproduced. 19 Hence there is insufficient evidence to determine if there is a malforming effect of clonazepam, gabapentin or lamotrigine. 12 An increased risk for smaller HC by epilepsy per se has been discussed, which could confound the findings of the effect of CBZ and VPA on bw-adj-HC reported here. However, such confounding by epilepsy indication is less likely in our study because four of the six AEDs studied (phenytoin, clonazepam, lamotrigine and gabapentin) showed very low mean SDS of bw-adj-HC, that is estimated not to reach significance using the CBZ monotherapy To analyze difference in effect over time we divided the material into three groups: 1995-1997, 1998-2001 and 2002-2005 . The use during pregnancy of CBZ was found to increase by 25% and VPA by 140%, between the first and last period in spite of recent reports on negative effects on newborns of these AEDs. The effect of VPA on mean bw-adj-HC changed over time and was lowest in the middle period (1998-2001) while no variation with time was seen for CBZ or all AEDs as a group.
In utero exposure to AED polytherapy, and monotherapy with VPA and phenytoin probably contribute to reduced cognitive outcome (reviewed by Harden et al. 12 ). Histopathologically, apoptotic neurodegeneration has been found in the brain after exposure of the young rodent to an AED (phenytoin, phenobarbital, diazepam, benzodiazepine, vigabatrin, and valproate), 20 which hypothetically could impair cognitive function. 21 In cell culture, CBZ has been shown to induce mitotic arrest, 22 and to inhibit differentiation of embryonic stem cells into later stages, whereas VPA was a potent inhibitor of all stages of mesodermal and endodermal development. 23 It is unknown if any of these mechanisms contributes to the, on average, small reduction in birth HC seen after in utero exposure to CBZ, VPA and AED polytherapy. The clinical significance, at birth and in the developing child, of the small reduction in birth HC associated with certain AED exposures in utero is unknown. The high plasticity of the nervous system at young age may compensate for disturbances. 24 
Conclusion
We have used a large nation-wide population-based material and shown that there is an apparent difference between AED drugs with respect to their effect on bw-adj-HC at birth. The strongest effects were seen for CBZ and VPA. The effects were small, but were statistically significant and remained from 1995 to 2005. CBZ or VPA were given to 71% of the cases, a prescription rate that increased with 25% for CBZ and 140% for VPA over the last decade. Phenytoin, clonazepam, lamotrigine and gabapentin had no certain effect on bw-adj-HC. AED polytherapy increased the rate of microcephaly.
